Nonprofit Trusted Source of Non-Commercial Health Information
Anti-Aging Medicine Market Place to exceed $300 Billion in 2018
LAS VEGAS (PRWEB)
“Longevity is now closer than ever,” said Dr. Ronald Klatz, MD, DO, President of the (A4M) American Academy of Anti-Aging, Preventative, and Regenerative Medicine. “1,000’s of top doctors and scientists from around the world gathered to express their utter amazement of the velocity with which longevity sciences are making strides toward the new targeted lifespan of 100 to 150 years of healthy aging. A new Multi-Billion Dollar pharmaceutical industry and biotech companies are popping up every day led by the likes of the Google, Gates and Company, and I host of household names. Revision Optics Rain Drop near vision inlay permanently corrects the front part of eye. They just raised several hundred million dollars. This is just one company. You can Google antiaging biotech companies easily come up with 50. Try and do that 25 years ago when Dr. Goldman and I started the American Academy of antiaging medicine.”
“Antiaging medicine which was once considered hyperbole and wishful thinking. It is now becoming mainstream practice for thousands, and thousands of medical professionals,” stated Dr. Klatz
This the 25th anniversary of the International World Congress of Antiaging and Regenerative Medicine produced representatives from Google, IBM Watson, Artificial Intelligence rock stars, Peter Diamandis from X Prize, and a line up of Advanced Medicine Superstars.
Experts from Major and Ivy League Universities addressed the audience affirming major progress in human genetic engineering, regenerative medicine, stem cell technologies, artificial intelligence for new drug involvement, innovative hormone replacement therapies designed not just to fight disease but the reverse the signs and symptoms of actual aging.
Antiaging and Regenerative Medicine which had its start in 1991 with Dr.Klatz, Dr. Goldman and a dozen physicians in Chicago has grown to a massive international movement now driving a new paradigm of healthcare quite apart from the old disease-based models to a new design of personalized, perspective, precision medicine is being adopted rapidly by all sectors medicine. The NIH has now classified Regenerative Medicine. This paradigm has been championed by the 28,000 doctors, scientists and other health professionals of the American Academy of Antiaging and Regenerative Medicine. A4M physicians are active in 120 nations across the globe providing care for hundreds of millions of patients worldwide. We are seeing major upticks in life expectancy across the world.
“This next focus is on individual unique metabolism and personalized biological risk factors. This is the way all healthcare will soon be practiced. 2018 will be even a more amazing year with the inclusion of millions of top level amateur athletes, sports trainers, sports physiologists, nutritionists, and lifestyle coaches to launch A4M Health and Fitness Research Projects,” said Dr. Robert: Chairman A4M chairman, founder and President Emeritus of National Academy of Sports Medicine (NASM)
The A4M Health & Fitness Projects are a constellation of physicians, scientists, Wall Street & Silicone Valley leaders combining with Elite Fitness & Sports performance professionals. The A4M Research Project will drive this new vision of healthcare into the dominant mainstream helping eliminate the horrors of our current disease-based, insurance code driven, medicine for “insurance based reimbursement only” disease care which has become the norm for Western medicine. All of this information is available free of charge to the public and the scientific community at http://www.Worldhealth.net.
The A4M has changed the face of healthcare dramatically over the last 25 years for the better. The A4M has driven healthcare to increase the lifespans, and quality of life for all peoples around the world. If you think that’s significant, wait till you see what we will accomplish the next 25 years.
Many international reporting agencies have are predicting the Anti-Aging Medicine Market Place to exceed $300 Billion in 2018.